Stay updated with breaking news from Keithj Sullivan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fielder Capital Group LLC bought a new stake in shares of Neuronetics, Inc. (NASDAQ:STIM – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor bought 22,797 shares of the company’s stock, valued at approximately $66,000. Other large investors also recently bought and sold shares of the company. FNY Investment Advisers LLC purchased […]
Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 94,600 shares, a growth of 77.8% from the March 15th total of 53,200 shares. Based on an average daily volume of 199,100 shares, the days-to-cover ratio is […]
The FDA has cleared NeuroStar® Advanced Therapy for use as an adjunct in the treatment of major depressive disorder in patients 15 to 21 years of age.
William Blair reissued their market perform rating on shares of Neuronetics (NASDAQ:STIM – Free Report) in a research note published on Tuesday morning, RTT News reports. Separately, Piper Sandler reaffirmed an overweight rating and issued a $8.00 target price (up from $7.00) on shares of Neuronetics in a research note on Wednesday, March 6th. Read […]
This treatment is now the first and only TMS treatment that is FDA-cleared for this patient population.